|

Evorpacept (ALX148) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • ALX Oncology Inc.1

Indications

  • Breast Cancer, Metastatic1
  • Breast Cancer1
  • Cancer1

Tucson, Arizona1 trial

ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies

The University of Arizona Cancer Center - North Campus

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.